# Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based Study

> **NCT04440540** · NA · TERMINATED · sponsor: **Chinese University of Hong Kong** · enrollment: 10 (actual)

## Conditions studied

- Non-alcoholic Fatty Liver Disease

## Interventions

- **BEHAVIORAL:** Dietitian led life style modification intervention
- **BEHAVIORAL:** Conventional care (control)

## Key facts

- **NCT ID:** NCT04440540
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-07-02
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-06-30
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** the patient recruitment was severely affected by COVID-19 pandemic
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04440540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04440540, "Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based Study". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04440540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*